Skip to main content
Have a personal or library account? Click to login
Biomechanical Characterization and Remodeling of Pulmonary Arteries in Chronic Thromboembolic Pulmonary Hypertension Cover

Biomechanical Characterization and Remodeling of Pulmonary Arteries in Chronic Thromboembolic Pulmonary Hypertension

Open Access
|Jun 2026

References

  1. Kim NH, Delcroix M, Jais X, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53(1). doi: 10.1183/13993003.01915-2018
  2. Chong C, Tay E, Sia C, Poh K. Chronic thromboembolic pulmonary hypertension: a review. SMEDJ. Published online 2021:318–325. doi: 10.11622/smedj.2021089
  3. Delcroix M, Torbicki A, Gopalan D, et al. ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J. 2021;57(6). doi: 10.1183/13993003.02828-2020
  4. Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J. 2022;43(38):3618–3731. doi: 10.1093/eurheartj/ehac237
  5. Cannon JE, Jenkins DP, Hoole SP. Chronic thromboembolic pulmonary hypertension: a review of risk factors, management and current challenges. Expert Rev Cardiovasc Ther. 2022;20(1):35–43. doi: 10.1080/14779072.2022.2034499
  6. Lutsey PL, Evensen LH, Thenappan T, et al. Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database. J Am Heart Assoc. 2022;11(14):e024358. doi: 10.1161/JAHA.121.024358
  7. Rosen K, Raanani E, Kogan A, et al. Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: Risk factors and management. J Heart Lung Transplant. 2022;41(2):208–216. doi: 10.1016/j.healun.2021.10.016
  8. Arbănași EM, Kaller R, Mureșan AV, Voidăzan S, Arbănași EM, Russu E. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935
  9. Mureșan AV, Russu E, Arbănași EM, et al. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management-A Single-Center Experience in Romania. J Clin Med. 2022;11(9):2452. doi: 10.3390/jcm11092452
  10. Halmaciu I, Arbănași EM, Kaller R, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients’ Mortality. Diagnostics. 2022;12(9):9. doi: 10.3390/diagnostics12092089
  11. Stoian M, Andone A, Boeriu A, et al. COVID-19 and Clostridioides difficile Coinfection Analysis in the Intensive Care Unit. Antibiotics. 2024;13(4):4. doi: 10.3390/antibiotics13040367
  12. Stoian A, Bajko Z, Stoian M, et al. The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature. Vaccines (Basel). 2023;11(7):1225. doi: 10.3390/vaccines11071225
  13. Hogea T, Suciu BA, Chinezu L, et al. Pregnancy-Associated Spontaneous Coronary Acute Dissection as a Cause of Sudden Cardiac Death—Autopsy Findings and Literature Review: Is COVID-19 Related? Medicina. 2023;59(7). doi: 10.3390/medicina59071257
  14. Arbănași EM, Halmaciu I, Kaller R, et al. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(10):10. doi: 10.3390/diagnostics12102379
  15. Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(11):11. doi: 10.3390/diagnostics12112757
  16. Jong CMM de, Visser C, Bemelmans RHH, et al. Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism. Eur Respir J. 2023;61(4). doi: 10.1183/13993003.00171-2023
  17. Cueto-Robledo G, Roldan-Valadez E, Graniel-Palafox LE, et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A Review of Another Sequel of Severe Post-Covid-19 Pneumonia. Curr Probl Cardiol. 2023;48(8):101187. doi: 10.1016/j.cpcardiol.2022.101187
  18. Caguana-Vélez OA, Khilzi K, Piccari L, et al. Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism in SARS-CoV-2. Respiration. 2024;103(2):79–87. doi: 10.1159/000536064
  19. Delcroix M, Kerr K, Fedullo P. Chronic Thromboembolic Pulmonary Hypertension. Epidemiology and Risk Factors. Annals ATS. 2016;13(Supplement_3):S201–S206. doi: 10.1513/AnnalsATS.201509-621AS
  20. Escribano-Subias P, Blanco I, López-Meseguer M, et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J. 2012;40(3):596–603. doi: 10.1183/09031936.00101211
  21. Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonaryhypertension(CTEPH):resultsfromaninternational prospective registry. Circulation. 2011;124(18):1973–1981. doi: 10.1161/CIRCULATIONAHA.110.015008
  22. Leber L, Beaudet A, Muller A. Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review. Pulm Circ. 2021;11(1):2045894020977300. doi: 10.1177/2045894020977300
  23. Simonneau G, Torbicki A, Dorfmüller P, Kim N. The pathophysiology of chronic thromboembolic pulmonary hypertension. Eur Resp Rev. 2017;26(143). doi: 10.1183/16000617.0112-2016
  24. Otani N, Watanabe R, Tomoe T, Toyoda S, Yasu T, Nakamoto T. Pathophysiology and Treatment of Chronic Thromboembolic Pulmonary Hypertension. Int J Mol Sci. 2023;24(4). doi: 10.3390/ijms24043979
  25. Simonneau G, Dorfmüller P, Guignabert C, Mercier O, Humbert M. Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology. Ann Cardiothorac Surg. 2022;11(2):10619–10119. doi: 10.21037/acs-2021-pte-10
  26. Lang IM, Dorfmüller P, Noordegraaf AV. The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Annals ATS. 2016;13(Supplement_3):S215–S221. doi: 10.1513/AnnalsATS.201509-620AS
  27. Sharma NK, Kaur S, Goel RK. Exploring the ameliorative role of α7 neuronal nicotinic acetylcholine receptor modulation in epilepsy and associated comorbidities in post-PTZ-kindled mice. Epilepsy & Behavior. 2020;103:106862. doi: 10.1016/j.yebeh.2019.106862
  28. Shahidi P, Mentzel L, Blazek S, et al. From Pulmonary Embolism to Chronic Thromboembolic Pulmonary Hypertension: A Pathophysiological Approach. Rev Cardiovasc Med. 2024;25(11). doi: 10.31083/j.rcm2511402
  29. Dorfmüller P, Günther S, Ghigna MR, et al. Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature. Eur Respir J. 2014;44(5):1275–1288. doi: 10.1183/09031936.00169113
  30. Jansa P, Ambrož D, Kuhn M, et al. Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic. Pulm Circ. 2022;12(1):e12038. doi: 10.1002/pul2.12038
  31. Kandathil A, Chamarthy M. Pulmonary vascular anatomy & anatomical variants. Cardiovasc Diagn Ther. 2018;8(3):20107–20207. doi: 10.21037/cdt.2018.01.04
  32. Gupta SK, Aggarwal A, Shaw M, et al. Clarifying the anatomy of common arterial trunk: a clinical study of 70 patients. Eur Heart J Cardiovasc Imaging. 2020;21(8):914–922. doi: 10.1093/ehjci/jez255
  33. Murota M, Yamamoto Y, Satoh K, et al. An analysis of anatomical variations of the left pulmonary artery of the interlobar portion for lung resection by three-dimensional CT pulmonary angiography and thin-section images. Jpn J Radiol. 2020;38(12):1158–1168. doi: 10.1007/s11604-020-01024-1
  34. Chikkabyrappa S, Mahadevaiah G, Buddhe S, Alsaied T, Tretter J. Common Arterial Trunk: Physiology, Imaging, and Management. Semin Cardiothorac Vasc Anesth. 2019;23(2):225–236. doi: 10.1177/1089253218821382
  35. Townsley MI. Structure and Composition of Pulmonary Arteries, Capillaries, and Veins. Comprehensive Physiology. 2012;2(1):675–709. doi: 10.1002/j.2040-4603.2012.tb00402.x
  36. Humbert M, Guignabert C, Bonnet S, et al. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 2019;53(1). doi: 10.1183/13993003.01887-2018
  37. Tuder RM. Pulmonary vascular remodeling in pulmonary hypertension. Cell Tissue Res. 2017;367(3):643–649. doi: 10.1007/s00441-016-2539-y
  38. Stenmark KR, Frid MG, Graham BB, Tuder RM. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension. Cardiovasc Res. 2018;114(4):551–564. doi: 10.1093/cvr/cvy004
  39. Dieffenbach PB, Maracle M, Tschumperlin DJ, Fredenburgh LE. Mechanobiological Feedback in Pulmonary Vascular Disease. Front Physiol. 2018;9. doi: 10.3389/fphys.2018.00951
  40. Jia Z, Wang S, Yan H, et al. Pulmonary Vascular Remodeling in Pulmonary Hypertension. J Pers Med. 2023;13(2). doi: 10.3390/jpm13020366
  41. Tobal R, Potjewijd J, Empel VPM van, et al. Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity. Front Med. 2021;8. doi: 10.3389/fmed.2021.806899
  42. Liu F, Haeger CM, Dieffenbach PB, et al. Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertension. JCI Insight. 2016;1(8). doi: 10.1172/jci.insight.86987
  43. Leopold JA, Maron BA. Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. Int J Mol Sci. 2016;17(5). doi: 10.3390/ijms17050761
  44. Singh I, Oliveira RKF, Naeije R, et al. Pulmonary Vascular Distensibility and Early Pulmonary Vascular Remodeling in Pulmonary Hypertension. CHEST. 2019;156(4):724–732. doi: 10.1016/j.chest.2019.04.111
  45. Rosenkranz S, Howard LS, Gomberg-Maitland M, Hoeper MM. Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure. Circulation. 2020;141(8):678–693. doi: 10.1161/CIRCULATIONAHA.116.022362
  46. Delcroix M, Noordegraaf AV, Fadel E, Lang I, Simonneau G, Naeije R. Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2012;41(1):224–232. doi: 10.1183/09031936.00047712
  47. Liu J, Yang P, Tian H, et al. Right ventricle remodeling in chronic thromboembolic pulmonary hypertension. J Transl Int Med. 2022;10(2):125–133. doi: 10.2478/jtim-2022-0027
  48. Avazmohammadi R, Mendiola EA, Li DS, Vanderslice P, Dixon RAF, Sacks MS. Interactions Between Structural Remodeling and Hypertrophy in the Right Ventricle in Response to Pulmonary Arterial Hypertension. J Biomech Eng. 2019;141(091016). doi: 10.1115/1.4044174
  49. Mendiola EA, da Silva Gonçalves Bos D, Leichter DM, et al. Right Ventricular Architectural Remodeling and Functional Adaptation in Pulmonary Hypertension. Circulation: Heart Failure. 2023;16(2):e009768. doi: 10.1161/CIRCHEARTFAILURE.122.009768
  50. Ren X, Johns RA, Gao WD. Right heart in pulmonary hypertension: from adaptation to failure. Pulm Circ. 2019;9(3):2045894019845611. doi: 10.1177/2045894019845611
  51. Avci BK, Basarici I, Akbulut M, et al. Comorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome. Medicina. 2025;61(5). doi: 10.3390/medicina61050827
  52. Singh S, Kumar P, Yadav SK, Jaffer FA, Reed GL. Recent Pathophysiological Insights Are Advancing the Treatment of Venous Thromboembolism. JACC: Basic to Translational Science. 2025;10(5):689–703. doi: 10.1016/j.jacbts.2024.12.004
  53. Lang IM, Campean IA, Sadushi-Kolici R, Badr-Eslam R, Gerges C, Skoro-Sajer N. Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension. Clin Chest Med. 2021;42(1):81–90. doi: 10.1016/j.ccm.2020.11.014
  54. Poch DS, Auger WR. Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes. Heart Fail Rev. 2016;21(3):309–322. doi: 10.1007/s10741-015-9518-3
  55. Staal DP, Hendriks PM, van Thor MCJ, et al. Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies. Pulm Circ. 2024;14(3):e12419. doi: 10.1002/pul2.12419
  56. Pengo V, Lensing AWA, Prins MH, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism. N Engl J Med. 2004;350(22):2257–2264. doi: 10.1056/NEJMoa032274
  57. Ende-Verhaar YM, Cannegieter SC, Noordegraaf AV, et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J. 2017;49(2). doi: 10.1183/13993003.01792-2016
  58. Morris TA, Marsh JJ, Chiles PG, et al. High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension. Blood. 2009;114(9):1929–1936. doi: 10.1182/blood-2009-03-208264
  59. Bonderman D, Turecek PL, Jakowitsch J, et al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2003;90(09):372–376. doi: 10.1160/TH03-02-0067
  60. Quarck R, Delcroix M. Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension? Eur Respir J. 2014;44(4):842–845. doi: 10.1183/09031936.00120014
  61. Magoń W, Stępniewski J, Waligóra M, et al. Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Cells. 2022;11(9). doi: 10.3390/cells11091491
  62. Roger I, Milara J, Montero P, Cortijo J. The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension. Int J Mol Sci. 2021;22(9). doi: 10.3390/ijms22094980
  63. Xu WJ, Wu Q, He WN, et al. Interleukin-6 and pulmonary hypertension: from physiopathology to therapy. Front Immunol. 2023;14. doi: 10.3389/fimmu.2023.1181987
  64. Berghausen EM, Feik L, Zierden M, Vantler M, Rosenkranz S. Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension. Herz. 2019;44(2):130–137. doi: 10.1007/s00059-019-4795-6
  65. Giaid A, Yanagisawa M, Langleben D, et al. Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension. N Engl J Med. 1993;328(24):1732–1739. doi: 10.1056/NEJM199306173282402
  66. Sharma S, Antoniak S. New Insights in the Pathology of Chronic Thromboembolic Pulmonary Hypertension*. JACC: Basic to Translational Science. 2024;9(1):117–119. doi: 10.1016/j.jacbts.2023.11.009
  67. Bochenek ML, Leidinger C, Rosinus NS, et al. Activated Endothelial TGFß1 Signaling Promotes Venous Thrombus Nonresolution in Mice Via Endothelin-1. Circ Res. 2020;126(2):162–181. doi: 10.1161/CIRCRESAHA.119.315259
  68. Bochenek ML, Saar K, Nazari-Jahantigh M, et al. Endothelial Overexpression of TGF-ß-Induced Protein Impairs Venous Thrombus Resolution. JACC: Basic to Translational Science. 2024;9(1):100–116. doi: 10.1016/j.jacbts.2023.08.005
  69. Pardali E, Sanchez-Duffhues G, Gomez-Puerto MC, Dijke PT. TGF-ß-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases. Int J Mol Sci. 2017;18(10). doi: 10.3390/ijms18102157
  70. Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003;76(5):1457–1464. doi: 10.1016/S0003-4975(03)00828-2
  71. Cannon JE, Su L, Kiely DG, et al. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy. Circulation. 2016;133(18):1761–1771. doi: 10.1161/CIRCULATIONAHA.115.019470
  72. Pillalamarri NR, Patnaik SS, Piskin S, Gueldner P, Finol EA. Ex Vivo Regional Mechanical Characterization of Porcine Pulmonary Arteries. Exp Mech. 2021;61(1):285–303. doi: 10.1007/s11340-020-00678-2
  73. Azadani AN, Chitsaz S, Matthews PB, et al. Regional mechanical properties of human pulmonary root used for the Ross operation. J Heart Valve Dis. 2012;21(4):527–534.
  74. Rogers NM, Yao M, Sembrat J, et al. Cellular, pharmacological, and biophysical evaluation of explanted lungs from a patient with sickle cell disease and severe pulmonary arterial hypertension. Pulm Circ. 2013;3(4):936–951. doi: 10.1086/674754
  75. Fata B, Carruthers CA, Gibson G, et al. Regional structural and biomechanical alterations of the ovine main pulmonary artery during postnatal growth. J Biomech Eng. 2013;135(2):021022. doi: 10.1115/1.4023389
  76. Cabrera MS, Oomens CWJ, Bouten CVC, Bogers AJJC, Hoerstrup SP, Baaijens FPT. Mechanical analysis of ovine and pediatric pulmonary artery for heart valve stent design. J Biomech. 2013;46(12):2075–2081. doi: 10.1016/j.jbiomech.2013.04.020
  77. Ion AP, Asztalos A, Ciucanu CC, et al. Optimizing Arterial Tissue Thickness Measurement Protocols: Digital Vernier Caliper Versus Digital Thickness Gauge. Methods and Protocols. 2024;7(6). doi: 10.3390/mps7060090
  78. Ion AP, Asztalos A, Ciucanu CC, et al. Superior Measurement Accuracy of Digital Thickness Gauge Versus Digital Vernier Caliper in Determining Venous Tissue Thickness. Cureus. 2024;16(9):e68442. doi: 10.7759/cureus.68442
  79. Arbănași EM, Russu E, Arbănași EM, et al. Effect of Ultraviolet Radiation on the Enzymolytic and Biomechanical Profiles of Abdominal Aortic Adventitia Tissue. J Clin Med. 2024;13(2). doi: 10.3390/jcm13020633
  80. Trâmbițaș C, Cordoș BA, Dorobanțu DC, et al. Application of Adipose Stem Cells in 3D Nerve Guidance Conduit Prevents Muscle Atrophy and Improves Distal Muscle Compliance in a Peripheral Nerve Regeneration Model. Bioengineering. 2024;11(2). doi: 10.3390/bioengineering11020184
  81. Arbănași EM, Chirilă TV. Preservation of human vascular tissue and the relevance of temperature: a narrative review. Front Bioeng Biotechnol. 2026;13. doi: 10.3389/fbioe.2025.1631214
DOI: https://doi.org/10.2478/jce-2026-0001 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 52 - 60
Submitted on: Jan 2, 2026
Accepted on: Feb 19, 2026
Published on: Jun 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Raysa-Ariana Mesani, Eliza Russu, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.